News

An interview with OMNY CEO and co-founder Mitesh Rao, M.D., and Johns Hopkins’ Alvin Liu, M.D., about the value of OMNY’s ...
Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies Xsolis Named Clinical ...
A panel at OCT Europe touched upon where the European clinical trial industry is headed and the impact of technology and ...
A study reveals higher health care costs and resource use for uncomplicated urinary tract infections (uUTIs), emphasizing the ...
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain ...
Company announcement - No. 11 / 2025 Zealand Pharma Announces Financial Results for the First Three Months of 2025 Significant progress in the clinical pipeline, strengthening of organizational capabi ...
WASHINGTON — In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his ...
Monthly issue of the UNRIC Info Point & Library Newsletter featuring new UN websites, publications and information products.
Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD) on track for the second half of 2025 -Streamlining operations and focusing on delivering ...
Tracy Vineis; Vice President, Communications; Apellis Pharmaceuticals Inc. Cedric Francois; President, Chief Executive Officer, Co-Founder, Director; Apellis Pharmac ...
The Advocate highlights social inequality through original stories and opinions, and content generated by fellow NNPA and ...